PHOENIX, AZ--(Marketwire - May 28, 2008) - Provista Life Sciences LLC, a diagnostic development and commercialization company, has been selected as one of five Phoenix-based organizations to participate in the Biotechnology Industry Organization’s 2008 BIO International Convention, to be held in San Diego June 17-20. Provista Life Sciences was chosen because of its work in the development of groundbreaking blood tests for the early detection of breast cancer and cancers in women as well as a test for the early detection of Alzheimer’s disease. The company most recently introduced its BT Test, or Biomarker Translation Test, to the market, designed to assist physicians in making an earlier and more accurate diagnosis of breast cancer when used in conjunction with a mammogram.
